Fatty liver disease (MASLD/MASH): open trials in Georgia

4 open trials have a site in Georgia. Registry data; only the trial team decides who can take part.

NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Ltd "Health", Batumi · Israeli-Georgian Medical Research Clinic Healthycore, LTD, Tbilisi
Registry updated 2026-10-28
NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Ltd "Health", Batumi · Israeli-Georgian Medical Research Clinic Healthycore, LTD, Tbilisi
Registry updated 2026-10-28
NCT06318169
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Batumi · Tbilisi
Registry updated 2026-10-23
NCT06419374
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Trial Treatment · Phase 3 · Hoffmann-La Roche
Tbilisi
Registry updated 2026-10-23

This page is not medical advice. Talk to your doctor before contacting a trial.

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis